Plasma services refers to the industry of collecting, processing, and distributing human blood plasma for use in life-saving medical treatments. This includes the network of dedicated plasma collection centers where donors give plasma through a specialized process, as well as the manufacturing facilities that turn that raw plasma into more than two dozen therapeutic products used worldwide. In the United States alone, plasma centers collected 62.5 million liters of plasma in 2025 from over 75 million donations.
What Plasma Is and Why It Matters
Plasma is the liquid portion of your blood, making up about 55% of total blood volume. It’s 91% to 92% water, with the remaining 8% to 9% consisting of proteins, electrolytes, and clotting factors. The proteins in plasma, particularly albumin, immunoglobulins (antibodies), and fibrinogen, are the reason plasma is so valuable to medicine. These proteins can be extracted and concentrated into therapies that treat conditions no synthetic drug can address.
The World Health Organization classifies plasma for fractionation as a strategic resource, and the medicines made from it are listed as essential. Unlike most pharmaceuticals, these treatments can only come from human donors. There is no lab-made substitute for many plasma-derived proteins.
How Plasma Collection Works
The vast majority of plasma used in manufacturing, between 85% and 90%, is collected at dedicated plasma centers through a process called apheresis. During apheresis, blood is drawn from a vein in your arm and fed into a machine that separates out the plasma. Your red blood cells, white blood cells, and platelets are then returned to your body through the same needle. You typically receive saline during the process to help maintain circulation.
This differs from a standard whole blood donation, where all components of your blood are collected at once. A whole blood draw takes about 20 minutes. An apheresis plasma donation takes roughly an hour once you’re hooked up to the machine, though your first visit can run up to two hours total because of the initial screening and physical exam.
Here’s what a typical visit looks like:
- Check-in: You present a valid photo ID, proof of address, and proof of Social Security number.
- Health screening: Every visit includes a blood sample, blood pressure reading, pulse check, and temperature measurement.
- Physical exam: Required on your first visit and at least once a year after that.
- Donation: The apheresis machine collects plasma and returns the rest of your blood. This takes about an hour.
- Recovery: You stay at the center for 10 to 15 minutes afterward to rehydrate and make sure you feel well enough to leave.
Who Can Donate Plasma
Requirements vary slightly between centers, but the general eligibility criteria are consistent. You need to be at least 18 years old, weigh at least 110 pounds, and pass a medical exam that includes testing negative for hepatitis and HIV. If you’ve gotten a tattoo or piercing within the last four months, most centers will ask you to wait. Centers also recommend following a diet that supports hydration and protein intake.
The FDA regulates how often you can donate: no more than twice in a seven-day period, with at least 48 hours between sessions. If you’ve donated whole blood, you need to wait eight weeks before donating plasma.
Compensation for Donors
Unlike whole blood donation at places like the Red Cross, plasma donation at commercial centers is compensated. Typical payments range from $30 to $70 per visit, though some centers pay $100 or more as of mid-2025. First-time donors often receive higher rates as an incentive. One major chain offers up to $750 for new donors at select locations, and another advertises up to $700 during a donor’s first month.
Donors who go twice a week consistently can earn $400 or more per month. Some high-frequency donors report making up to $1,000 monthly, especially when referral bonuses and loyalty programs are factored in.
What Plasma Services Produce
Once collected, plasma is sent to fractionation facilities where it’s separated into individual protein components. This manufacturing process takes months from start to finish, which means any disruption in donations creates supply shortages that ripple through the healthcare system well after the fact.
The resulting products treat a wide range of serious conditions:
- Immunoglobulin therapies: Pooled antibodies extracted from plasma are used to treat people with primary immunodeficiencies, where the body can’t produce enough antibodies on its own. They’re also used for autoimmune conditions like immune thrombocytopenic purpura (a dangerous bleeding disorder), Kawasaki disease, and multifocal motor neuropathy.
- Albumin: Used to manage blood volume in critically ill patients, burn victims, and people undergoing major surgery.
- Clotting factors: Essential for people with hemophilia and other bleeding disorders.
- Hyperimmune globulins: Specialized antibody products used for post-exposure protection against specific infections, including hepatitis A and B, tetanus, rabies, and respiratory syncytial virus.
Immunoglobulin therapy alone is used across cancer care (for certain leukemias and lymphomas that suppress the immune system), bone marrow transplant recovery, HIV management, and rare inflammatory conditions like toxic epidermal necrolysis and toxic shock syndrome.
Side Effects and Safety for Donors
Most side effects from plasma donation are mild. The most common include lightheadedness or fainting (vasovagal reactions), dehydration, arm soreness at the needle site, and tingling or numbness from citrate, the anticoagulant used during the collection process. Serious complications are rare, and any problems after leaving the center are uncommon.
Some research suggests that donating more frequently may slightly increase the chance of minor side effects, though experienced donors tend to tolerate the process better over time. Staying well-hydrated and eating a protein-rich meal before your appointment are the simplest ways to reduce discomfort.
The Scale of the Industry
Plasma services is a massive global industry, and the United States is by far its largest contributor. U.S. plasma collection grew 8.4% from 2024 to 2025, reaching 62.5 million liters. The country’s network of thousands of collection centers supplies the majority of the world’s plasma-derived medicines, making donor participation a genuinely critical part of the healthcare supply chain for patients with rare and life-threatening diseases.